Woman With Bipolar Disorder: Hispanic Male Client Treatment Treatment

Hispanic Male Client Treatment
Author’s Name
Institutional Affiliation
Hispanic Male Client Treatment
Introduction
Bipolar disorder is a quite common disease. It is an extreme mental disorder and about one or two people in an adult population are effected with this disorder. The symptoms of bipolar disorder vary according to the type of episode that may be depressive or manic. The type of mood and physical actions of the person decides the episode type ADDIN EN.CITE Grande2016950(Grande, Berk, Birmaher, & Vieta, 2016)95095017Grande, IriaBerk, MichaelBirmaher, BorisVieta, EduardBipolar disorderThe LancetThe Lancet1561-15723871002720160140-6736(Grande, Berk, Birmaher, & Vieta, 2016). The patient’s thinking, behavior, and sudden change in an attitude are the signs of mental illness. At times, such changes are sudden and people in surrounding notice such kind of change ADDIN EN.CITE Michelini2016946(Michelini et al., 2016)94694617Michelini, GKitsune, GLHosang, Georgina MAsherson, PhilipMcLoughlin, GráinneKuntsi, JonnaDisorder-specific and shared neurophysiological impairments of attention and inhibition in women with attention-deficit/hyperactivity disorder and women with bipolar disorderPsychological medicinePsychological medicine493-50446320160033-2917(Michelini et al., 2016). This type of unpredictable mood disorder can effect anyone at any stage of life and poor or rich can be equally effected with this disorder. Mostly, people who are 25 or more are effected with bipolar disorder. Teenagers are not effected by this disorder.
The Bipolar disorder should not take for granted because it gets complicated with time. If the bipolar disorder is identified at an early stage then it can be treated with the help of medication and psychotherapy ADDIN EN.CITE Perich2017951(Perich et al., 2017)95195117Perich, Tania ARoberts, GloriaFrankland, AndrewSinbandhit, CarinaMeade, TanyaAustin, Marie-PaulMitchell, Philip BClinical characteristics of women with reproductive cycle–associated bipolar disorder symptomsAustralian & New Zealand Journal of PsychiatryAustralian & New Zealand Journal of Psychiatry161-16751220170004-8674(Perich et al., 2017). It is necessary to develop a sound relation with the patient to take care of the patient effectively. In the current case study, an Asian American Woman is suffering from a bipolar disorder. For her treatment, three safe and suitable options are suggested and their possible outcomes are described. The patient is an Asian American Woman and her age is 26 and belongs to Korean descent. Her weight is 110 Ibs and her height is 5’5’’. Lab studies related to her condition were normal. As per her genetic test report, she has CYP2D6*10 allele. Her dress sense is getting odd in every appointment. She speaks rapidly and under pressure. She denies any hallucination and suicidal ideation.
Decision # 1
Selected Decision
As per decision # 1, the best solution is to treat the bipolar disorder of the patient with the help of Risperdal 2 mg. Just give it to the patient twice a day. Risperdal is also known as risperidone that is from a class benzisoxazole derivative that are antipsychotic drugs ADDIN EN.CITE Vink2015947(Vink, 2015)94794717Vink, Chelsea MThe Pharmacokinetics of Risperdal and its Weight Gaining Side Effects in Adolescents with Irritability Due to Autism and Disruptive Behavior Disorders2015(Vink, 2015). It is quite effectual to cure bipolar disorder. The lithium prescription was already given to the patient but she did not show any considerable improvement. Therefore, it is appropriate to give Risperdal to the patient that is quite effective and well known to treat bipolar disorders and other mental illnesses.
Reason to Select the Decision
The foremost reason to select the Risperdal is that it is used to treat the patients of schizophrenia. It is useful to stabilize brain activities and helps it to function in a normal way. Risperdal enhances the thinking mechanism by maintaining the balance of serotonin and dopamine ADDIN EN.CITE Fellner2017952(Fellner, 2017)95295217Fellner, ChrisNew schizophrenia treatments address unmet clinical needsPharmacy and TherapeuticsPharmacy and Therapeutics1304222017(Fellner, 2017). This drug is also very effective to treat bipolar disorder and bad temper. To make the temperament of the patient better and to enhance the mental capabilities, the Risperdal is the best option.
Possible Achievement from the Decision
With the help of this treatment, the patient should be able to communicate in a better way. She should show a significant change in her verbal communication within the first month of the management. It is expected from the patient to tell her brain clarity in her first visit right after the initiation of the treatment ADDIN EN.CITE Jeon2018953(Jeon, 2018)95395317Jeon, Hong JinStrategies of Using Antipsychotics in Patients with Bipolar DisordersJournal of Korean Neuropsychiatric AssociationJournal of Korean Neuropsychiatric Association301-30757420181015-4817(Jeon, 2018). She should free from any doubt or ambiguity. Normally, Lithium and anticonvulsants are given to patients who are affected by bipolar disorder. The latest study reveals that 74% of the patients quit prescribed medication by the PMNHP because of intolerance and inefficiency PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DaG91PC9BdXRob3I+PFllYXI+MjAxNTwvWWVhcj48UmVj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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DaG91PC9BdXRob3I+PFllYXI+MjAxNTwvWWVhcj48UmVj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ADDIN EN.CITE.DATA (Chou et al., 2015). In the present case study, the Asian American woman discontinued her lithium drugs when she discharged from the hospital. For that reason, there is a need to monitor the patient by family members at home. It is essential for the patients to take medicines on time for the recovery. There is no use to take medicines after weeks or days because the proper mental illness treatment needs consistency. People who take the treatment for granted and do not bother prescriptions experience severe mental states afterwards.
Expectations and Outcomes of Decision # 1
Difference between the expectation and an actual outcome of after a month of the treatment reveals that she improved a little. The patient complained about drowsiness. The sleepiness is a side effect of the drug Risperdal ADDIN EN.CITE Bhandari2018954(Bhandari, 2018)95495417Bhandari, SmithaBipolar Disorder or ADHD? Diagnosing teens with both the conditionsMental Health MattersMental Health Matters15-16512018(Bhandari, 2018). Her genetic testing shows that she is positive for CYP2D6. It has been reported that pharmacokinetics of controlled paroxetine after particular supervision was stimulated by CYP2D6 ADDIN EN.CITE Chen2015945(Chen, Wang, Shi, Shen, & Hu, 2015)94594517Chen, RuiWang, HaotianShi, JunShen, KaiHu, PeiCytochrome P450 2D6 genotype affects the pharmacokinetics of controlled-release paroxetine in healthy Chinese subjects: comparison of traditional phenotype and activity score systemsEuropean journal of clinical pharmacologyEuropean journal of clinical pharmacology835-84171720150031-6970(Chen, Wang, Shi, Shen, & Hu, 2015). It is better to lessen the dose of medication to overcome drowsiness. The positive result to reduce the dosage should be some betterment in the patient. For instance, a patient should be able to sleep with more absorption. Daytime drowsiness is a side effect of the Risperdal to treat the mental disorder.
Decision # 2
Selected Decision
The second option is not to quit Risperdal and lessen the Risperdal dosage. It is better to take 1mg in sleep hours. The patient and family reported that the 2mg Risperdal makes the patient drowsy the whole day. At the same time, the patient showed signs of recovery after taking Risperdal. If the patient discontinues medicine then the PMHNP has to prescribe another drug to treat the mental illness ADDIN EN.CITE Valentín2017955(Valentín, 2017)95595517Valentín, MSAn Overview of the Neurological Base of Bipolar DisorderJ Child Dev DisordJ Child Dev Disord20342017(Valentín, 2017). To check the effect of the drug, it will take weeks. In the case of an ineffective drug, the time of the patient will be wasted. Therefore, it is better to prescribe Risperdal with a minimum dosage.
Reason to Select the Decision
Risperdal is effectual to treat the patient mental illness. The patient shows positive signs of recovery. Therefore, I will continue to give Risperdal but with lower quantity. A close assessment of the patient will be done after giving 1mg Risperdal.
Possible Achievement from the Decision
The possible outcome of taking Risperdal 1mg at night is helpful to eliminate the sleepiness and toxicity within the patient. With the help of this dosage, it is expected to get positive results. The patient should show betterment in health and decline in the bipolar disorder. The patient family can easily observe the effects of medicine and they can describe it to the doctor for the fastest recovery.
Expectations and Outcomes of Decision # 2
After taking the medicine for four weeks, the patient starts to show a significant improvement in her activities and behavior. The therapeutic effect of the Risperdal was quite noteworthy. 1mg dose of Risperdal at night gives very positive outcomes and it makes the patient tolerant and she starts adjusting with the environment in a convenient way. There was a zero drowsiness and the patient experiences no toxicity ADDIN EN.CITE Vink2015947(Vink, 2015)94794717Vink, Chelsea MThe Pharmacokinetics of Risperdal and its Weight Gaining Side Effects in Adolescents with Irritability Due to Autism and Disruptive Behavior Disorders2015(Vink, 2015). Therefore, it can be concluded that the expected outcomes and the actual results are the same. For the progress in the health status, there is a need to do close monitoring of the patient. Continue to give Risperdal with the same dosage for four weeks to monitor the further improvement.
Decision # 3
Selected Decision
The third decision is to take the Risperdal 1mg dosage at night continuously. The decision is only made for the benefit of the patient. If the condition of the patient is getting better with the previous decision then it is essential to continue the treatment until the patient fully recovered. The discontinuation of the drug is not possible at this stage because the patient already shows a recovery sign with the help of Risper...